Home › Funds › CONTINENTAL ADVISORS LLC › TEVA

CONTINENTAL ADVISORS LLC position in TEVA

TEVA PHARMACEUTICAL INDS LTD · Health Care

CONTINENTAL ADVISORS LLC reported holding 40,000 shares of TEVA (TEVA PHARMACEUTICAL INDS LTD) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 0.86% of its reported portfolio and ranking #30 among its reported holdings. CONTINENTAL ADVISORS LLC has disclosed TEVA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)40.00K sh
Reported value held$1.58M
Portfolio Weight0.86%
First reportedQ3 2023
Last changeReduce
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How CONTINENTAL ADVISORS LLC's TEVA position evolved

CONTINENTAL ADVISORS LLC first disclosed a stake in TEVA in Q3 2023 at 155,400 shares (US$1.6M). The position peaked in Q4 2025 at 288,118 shares, worth US$9.0M. Across 13 filings, CONTINENTAL ADVISORS LLC increased the stake 2 time(s), trimmed it 7 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 40,000 shares valued at US$1.6M — a reduction of -192,118 shares quarter over quarter.. Notable position changes include a 97% increase in Q4 2023 (shares rose 35% over the following quarter), a 56% increase in Q1 2024 (shares rose 15% over the following quarter), a 83% trim in Q3 2026 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 155.40K $1.59M New
Q4 2023 305.40K $3.19M Add
Q1 2024 477.77K $6.74M Add
Q2 2024 403.77K $6.56M Reduce
Q3 2024 361.62K $6.52M Reduce
Q4 2024 341.12K $7.52M Reduce
Q1 2025 341.12K $5.24M Hold
Q2 2025 341.12K $5.72M Hold
Q3 2025 341.12K $6.89M Hold
Q4 2025 288.12K $8.99M Reduce
Q1 2026 242.12K $7.29M Reduce
Q2 2026 232.12K $7.86M Reduce
Q3 2026 40.00K $1.58M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TEVA and 13F data

TEVA (TEVA PHARMACEUTICAL INDS LTD) is a Health Care company. 43 other funds we track also report a position in TEVA — the largest reported positions include Harel Insurance Investments & Financial Services Ltd. (US$1.63B), Phoenix Financial Ltd. (US$1.45B), WCM INVESTMENT MANAGEMENT, LLC (US$1.38B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TEVA

All TEVA fund holders →

FAQ

How long has CONTINENTAL ADVISORS LLC held TEVA?

CONTINENTAL ADVISORS LLC has disclosed TEVA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CONTINENTAL ADVISORS LLC's current position in TEVA?

As of Q3 2026, CONTINENTAL ADVISORS LLC holds 40.00K shares of TEVA (TEVA PHARMACEUTICAL INDS LTD), valued at $1.58M, representing 0.86% of its reported portfolio and ranking #30.

Has CONTINENTAL ADVISORS LLC been buying or selling TEVA?

In the latest 13F filing (Q3 2026), CONTINENTAL ADVISORS LLC reduced its position in TEVA. The position peaked in Q4 2025 at 288.12K shares.

Which other funds hold TEVA?

Other major institutional holders of TEVA include Harel Insurance Investments & Financial Services Ltd., Phoenix Financial Ltd., WCM INVESTMENT MANAGEMENT, LLC, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.